Your browser does not support JavaScript!
Logo de Labiotech.eu

Labiotech.eu Source d'actualité

Une actualité de Labiotech.eu a été ajouté(e)
Aujourd'hui à 16:57
Harvard spin-off cellvie closes $5.5M new funding
cellvie Inc., which works on therapeutic mitochondria transplantation (TMT), an approach developed at Harvard Medical School, has closed a $5.5 million financing to get Series A-ready by the end of...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Aujourd'hui à 12:12
Evonetix closes $24M financing
Evonetix Ltd, a synthetic biology company bringing semiconductor technology to DNA synthesis, has completed a $24 million financing round, extending its total series B funding to over $54 million....
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Aujourd'hui à 08:34
Antibody candidate for treating serious liver disease
There is currently no drug for treating non-alcoholic fatty liver disease, which affects many people with type 2 diabetes and which can result in other serious liver diseases. However, a new study...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Hier à 16:57
Genoscience Pharma receives orphan drug designation for hepatocellular carcinoma drug
Genoscience Pharma has announced that its lead candidate, ezurpimtrostat, a PPT-1 (Palmitoyl Protein Thioesterase-1) inhibitor, has been granted orphan drug designation (ODD) by the US Food and Drug...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Hier à 12:12
AI boosts genome editing
Researchers at the University of Zurich have developed a new tool that uses artificial intelligence to predict the efficacy of various genome-editing repair options. Unintentional errors in the...
www.labiotech.eu
Charger plus d'actualités

Informations juridiques
SIREN / SIRET - DE Labiotech

Adresse
Berlin Berlin DE Allemagne